<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02416869</url>
  </required_header>
  <id_info>
    <org_study_id>36/11-2013</org_study_id>
    <nct_id>NCT02416869</nct_id>
  </id_info>
  <brief_title>Dexamethasone in Lower Third Molar Surgery</brief_title>
  <official_title>Effectiveness of Different Application Modalities of Dexamethasone on Clinical Parameters and Quality of Life After Lower Third Molar Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Belgrade</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Belgrade</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this randomized double-blind cross over clinical trial is to investigate
      effectiveness of different routes of applications (intramuscular and submucous at the site of
      surgery) and doses (4 mg and 8 mg) of Dexamethasone on swelling, trismus, pain and quality of
      life after lower third molar surgery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Facial swelling (using 3 facial measurements (in millimeters)</measure>
    <time_frame>1 day, 3 day, 7 day</time_frame>
    <description>We followed facial swelling 1, 3 and 7 days after intervention.
Swelling in the operation site will be evaluated using 3 facial measurements (in millimeters):
Tragus - Midline.
Tragus - Corner of the mouth
Gonion - Lateral canthus.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain (visual analog scale)</measure>
    <time_frame>1 day, 3 day, 7 day</time_frame>
    <description>Postoperative pain will be evaluated using a visual analog scale, 100 mm in length ranging from 0 for &quot; no pain&quot; to 100 for &quot;the worse imaginable pain&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative trismus (difference in interincisal distance at the maximal mouth opening (in millimeters) before and after surgery)</measure>
    <time_frame>1 day, 3 day, 7 day</time_frame>
    <description>Postoperative trismus will be measured as the difference in interincisal distance at the maximal mouth opening (in millimeters) before and after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative discomfort (25-items custom made questionnaire)</measure>
    <time_frame>4 day, 7 day</time_frame>
    <description>Postoperative discomfort will be evaluated by filling out the 25-items custom made questionnaire that was designed to asses the patient's perception of adverse effects.</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Impacted Third Molar Tooth</condition>
  <arm_group>
    <arm_group_label>Intramuscular application</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intramuscular application of 4mg Dexamethasone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Submucosal application</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Submucosal application of 4mg Dexamethasone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4mg Dexamethasone submucosal</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>4mg Dexamethasone submucosal application</description>
  </arm_group>
  <arm_group>
    <arm_group_label>8mg Dexamethasone submucosal</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>8mg Dexamethasone submucosal application</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4mg Dexamethasone postoperative</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>4mg Dexamethasone postoperative application</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4mg Dexamethasone preoperative</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4mg Dexamethasone postoperative application</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intramuscular application</intervention_name>
    <description>Patient receive 4mg of Dexamethasone by intramuscular application</description>
    <arm_group_label>Intramuscular application</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Submucosal application</intervention_name>
    <description>Patients receive 4mg of Dexamethasone by submucosal application</description>
    <arm_group_label>Submucosal application</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>4mg Dexamethasone submucosal</intervention_name>
    <description>Patients receive 4mg of submucosal Dexamethasone</description>
    <arm_group_label>4mg Dexamethasone submucosal</arm_group_label>
    <other_name>Dexasone</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>8mg Dexamethasone submucosal</intervention_name>
    <description>Patients receive 8mg of submucosal Dexamethasone</description>
    <arm_group_label>8mg Dexamethasone submucosal</arm_group_label>
    <other_name>Dexasone</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>4mg Dexamethasone preoperative</intervention_name>
    <description>Patients receive 4mg of Dexamethasone preoperatively</description>
    <arm_group_label>4mg Dexamethasone postoperative</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>4mg Dexamethasone postoperative</intervention_name>
    <description>Patients receive 4mg of Dexamethasone postoperatively</description>
    <arm_group_label>4mg Dexamethasone preoperative</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy patients (ASA I)

          -  Bilateral symmetrically impacted lower third molars according to Pel-Gregory's and
             Winter's classification

        Exclusion Criteria:

          -  Heavy tobacco smokers

          -  Drug and / or alcohol abusers
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Miroslav M Andric, DDS, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>School of Dental Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Miroslav M Andric, DDS, PhD</last_name>
    <phone>00381112685864</phone>
    <phone_ext>244</phone_ext>
    <email>miroslav.andric@stomf.bg.ac.rs</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Vladimir S Todorovic, DDS, MSc</last_name>
    <email>todent@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>School of Dental Medicine</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miroslav M Andric, DDS, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Vladimir S Todorovic, DDS, MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aleksandar S Jakovljevic, DDS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Miroslav R Vasovic, DDS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Serbia</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 2, 2015</study_first_submitted>
  <study_first_submitted_qc>April 14, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 15, 2015</study_first_posted>
  <last_update_submitted>May 3, 2017</last_update_submitted>
  <last_update_submitted_qc>May 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Belgrade</investigator_affiliation>
    <investigator_full_name>Miroslav Andric</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Dexamethasone</keyword>
  <keyword>Lower third molar surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tooth, Impacted</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

